Key takeaways
- Grade D for longevity/anti-ageing in humans — compelling animal data has not translated to reliable human benefit.
- Grade C (inconsistent) for cardiometabolic markers such as blood pressure, glucose and lipids.
- Typical trial doses range from 150-500 mg/day, but poor bioavailability limits how much reaches tissues.
- Notable drug interactions: avoid with anticoagulants (e.g. warfarin) and oestrogen-sensitive conditions; avoid in pregnancy.
- Our verdict: Skip — the money is better spent on evidence-backed supplements such as omega-3, vitamin D or creatine.
What the evidence says
- Cardiometabolic markers (blood pressure, glucose, lipids)C
- Longevity / anti-ageing in humansD
What Is Resveratrol?
Resveratrol is a polyphenol found in grape skins, red wine, blueberries, and Japanese knotweed (Polygonum cuspidatum — the most concentrated supplement source). It attracted intense scientific interest after studies in yeast, worms, flies and mice showed it activated sirtuin pathways (particularly SIRT1) linked to calorie restriction and extended lifespan. The popular press ran with it. Supplement sales soared. And then the human trials started arriving.
The story since then has been one of repeated disappointment — not because resveratrol is harmful, but because the leap from petri dish and mouse to living, breathing human has not held up.
Does It Work? The Evidence
Longevity / anti-ageing — Grade D
There is no credible human evidence that resveratrol extends lifespan, meaningfully slows biological ageing, or replicates the sirtuin-driven effects seen in animal models. Multiple well-designed human trials have failed to demonstrate that resveratrol supplementation produces the metabolic shifts its mechanisms predict. A comprehensive review published in Nutrients (2018) examined the available human data and concluded that outcomes were inconsistent and effect sizes were too small or absent to justify therapeutic use for longevity. Grade: D — insufficient or no human benefit demonstrated.
Cardiometabolic markers — Grade C
Some trials have reported modest reductions in blood pressure, LDL cholesterol, fasting glucose or inflammatory markers (e.g. CRP, IL-6). However, the results are inconsistent across studies: some show benefit, others show none. Meta-analyses find small, heterogeneous effects that differ by population, dose, and baseline health status. The Nutrients 2018 human review found that cardiometabolic results varied widely depending on whether participants had pre-existing metabolic dysfunction. In generally healthy adults, effects are negligible. Grade: C — limited and inconsistent.
Put plainly: resveratrol has not earned a place in a supplement stack for healthy, active adults.
How to Take It
Human trials have used doses ranging from 150 mg/day to 1,000 mg/day, with no clear dose-response relationship established. Poor oral bioavailability is the central problem — resveratrol is rapidly metabolised in the gut and liver, meaning only a fraction of the dose reaches target tissues in meaningful concentrations. Formulations with enhanced bioavailability (micronised, liposomal, or combined with piperine) exist but have limited clinical validation.
If you choose to take it despite the weak evidence, 150-500 mg/day with food is the most commonly studied range. Higher doses increase GI side-effect risk without proven additional benefit.
General information, not medical advice — check with a GP or pharmacist before starting, especially if pregnant, breastfeeding, under 18, or on medication.
Who Should Take It — and Who Shouldn't
Skip it if you are: on anticoagulants (warfarin, apixaban, rivaroxaban) — resveratrol inhibits CYP2C9 and has antiplatelet properties, raising bleeding risk and potentially increasing drug plasma levels. Also avoid if you have an oestrogen-sensitive condition (resveratrol has weak phyto-oestrogenic activity), or if you are pregnant or breastfeeding (safety data absent).
Who might monitor the field: researchers, biohackers tracking the longevity literature, or individuals with specific cardiometabolic concerns discussed with a GP. But even here, the evidence does not yet justify a strong recommendation — and other supplements have far more robust human data.
If healthy ageing and long-term body composition are your goals, the evidence-backed priorities are structured training, high-protein nutrition (use our protein calculator to hit your target), quality sleep, and well-evidenced supplements like omega-3, vitamin D and creatine — all with Grade A or B human evidence.
Safety and Interactions
Resveratrol is generally well tolerated at 150-500 mg/day. The main concerns are:
- GI effects: nausea, diarrhoea and abdominal discomfort, particularly at doses >=1 g/day.
- CYP enzyme inhibition: resveratrol inhibits CYP2C9 and CYP3A4, which metabolise a wide range of drugs including warfarin, some statins, ciclosporin, and certain blood-pressure medications. This can increase drug plasma levels and risk of adverse effects.
- Antiplatelet activity: adds to bleeding risk when combined with anticoagulants or antiplatelet drugs.
- Oestrogenic activity: weak phyto-oestrogen — uncertain clinical significance, but worth flagging in hormone-sensitive conditions.
- Long-term safety: human data beyond 12 months is sparse.
How to Buy It Well
If you decide to purchase resveratrol, choose a product with:
- Third-party testing — heavy-metal contamination is a concern with Polygonum cuspidatum extracts; look for brands tested by accredited labs.
- Specified form and standardisation — trans-resveratrol (the active isomer) rather than cis-resveratrol; standardised percentage of the extract.
- Transparent dosing — avoid proprietary blends that obscure dose per capsule.
- No inflated longevity claims — if the label says 'extends lifespan' or 'activates sirtuins like caloric restriction,' the marketing is ahead of the science.
Given the grade D evidence, though, our honest advice is to put your budget towards supplements that actually have strong human data behind them.
The Verdict
Resveratrol is one of nutrition science's great what-ifs. The mechanistic story is elegant; the animal data is compelling; the human outcomes are underwhelming. After years of research, no consistent human longevity benefit has been demonstrated, and cardiometabolic results are too mixed to rely on. For most people, it is a supplement that promises a great deal and delivers very little in practice.
Skip it. Redirect the budget to omega-3 fish oil (Grade A for triglycerides), vitamin D (Grade A for deficiency — highly prevalent in the UK), or creatine (Grade A for strength and lean mass). These are the supplements worth your money.
Supplements are roughly 5% of the result — the other 95% is training, nutrition, sleep and consistency, done right. A coach makes sure all of it works together. Book a free consultation and let's build a plan that actually moves the needle. Or start with the free Physique Blueprint quiz to see exactly where your biggest gains are hiding.
Supplements are about 5% of the result. A coach gets the other 95% right.
Book a free consultationSafety & interactions
Generally well tolerated at typical doses; GI side effects (nausea, diarrhoea, abdominal discomfort) reported at higher doses (>=1 g/day). Inhibits CYP2C9 and CYP3A4 enzymes, potentially raising plasma levels of warfarin, statins, and other drugs — consult a GP or pharmacist before combining. Long-term safety data in humans is limited.
Avoid / check first if: On anticoagulants (e.g. warfarin, apixaban) — resveratrol has antiplatelet and CYP-enzyme-inhibiting properties that may alter drug levels and bleeding risk. Oestrogen-sensitive conditions (e.g. breast cancer, endometriosis) — resveratrol has weak oestrogenic activity. Pregnant or breastfeeding — insufficient safety data.
General information, not medical advice. Check with a GP or pharmacist before starting a supplement — especially if you are pregnant, breastfeeding, under 18, or taking any medication.
Sources & further reading
- Examine — Resveratrol — Examine
- Health Effects of Resveratrol: Results from Human Intervention Trials (Nutrients 2018) — MDPI Nutrients / PubMed
Citations are provided for transparency. This is general information, not medical advice — always consult a qualified professional about your own circumstances.